Project
SAKK 66/22 - Invincible 4 SAKK
Ongoing - recruitment active · 2024 until 2029
Jörger Markus, Dei Cas Alissa, Müller Fiona
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Ongoing - recruitment active
Start Date
2024
End Date
2029
Financing
SAKK
Labels
breast cancer
Brief description/objective
Protocol SAKK 66/22: Intratumoral INT230-6 followed by neoadjuvant immunochemotherapy in patients with early triple-negative breast cancer (TNBC). An openlabel randomized two-cohort phase 2 clinical trial. INVINCIBLE-4-SAKK